Gastrointestinal Cancer

The Pharmacy Times® Gastrointestinal Cancer Resource Center is a comprehensive resource for clinical news and expert insights on cancers that occur in digestive tract organs, such as the stomach, large and small intestine, pancreas, colon, liver, rectum, anus, and biliary system.

“Diversity Equals Health”; A Diverse Gut Microbiome Could Be Driving Factor to Protect Against COVID-19

November 16, 2022

Article

Like using good nutrients to grow tomatoes in the soil, good nutrients and diverse microbes are important for our good gut health, or our gut's "garden," said a leading researcher.

Resistant Starch in Foods Can Reduce Hereditary Cancer by 50%

August 03, 2022

Article

Findings in a new trial show that dietary supplementation of resistant starch has the potential to decrease people’s risk of certain types of gastrointestinal cancers.

FDA Approves Dabrafenib Plus Trametinib for Unresectable, Metastatic Solid Tumors With BRAF V600E Mutation

June 23, 2022

Article

In clinical trials, dabrafenib and trametinib showed meaningful efficacy in multiple BRAF-positive tumor types, including in patients with rare cancers who have no other treatment options available.

Antibiotic Use, Inflammatory Bowel Disease Related in Older Adults

May 27, 2022

Article

Any antibiotic use was associated with higher rates of IBD, and the risk went up substantially with each course.

Pharmacy Focus Episode 44: Psychosocial Outcomes in Patients with IBD

April 01, 2022

Podcast

There is more to patients with IBD than the physical detriments, with many mental health issues arising from the condition.

Daily Medication Pearl: Trastuzumab

March 28, 2022

Article

Trastuzumab (Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant) is a HER2/neu receptor antagonist indicated for early and advanced breast cancer, advanced stomach cancer, and gastroesophageal junction cancer.

Study: Weight Loss Reduces Risk of Growths Linked to Colorectal Cancer

February 02, 2022

Article

The research team suggests that healthy weight maintenance throughout adulthood is crucial in preventing colorectal adenoma.

Pharmacy Clinical Pearl of the Day: Gastrointestinal Stromal Tumors

January 04, 2022

Article

Small GISTs may cause no symptoms and may grow so slowly that they have no serious effects.

Dostarlimab-gxly Receives FDA Accelerated Approval for Adult Patients with dMMR Recurrent, Advanced Solid Tumors

August 18, 2021

Article

The continued approval for this indication may be subject upon verification and description of clinical benefit in a confirmatory trial.

Oncology Overview: Taking a Closer Look at Nivolumab Immunotherapy

July 12, 2021

Article

Nivolumab (Opdivo; Bristol Myers Squibb) is FDA approved for 11 cancer indications, with the most recent approval for use in combination with certain chemotherapy for the initial treatment of gastric cancer.